An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma.

@article{Pisegna1993AnEO,
  title={An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma.},
  author={Joseph R Pisegna and G G Slimak and John L. Doppman and Doris B. Strader and David C. Metz and Richard V. Benya and Murray Orbuch and Vitaly A. Fishbeyn and Douglas L. Fraker and Jeffrey A. Norton},
  journal={Gastroenterology},
  year={1993},
  volume={105 4},
  pages={1179-83}
}
BACKGROUND Metastatic gastrinoma is becoming increasingly recognized in patients with Zollinger-Ellison Syndrome. The mean 5-year survival of these patients is < 20%. Chemotherapeutic regimens are of limited benefit. The aim of this study was to evaluate the use of interferon in these patients because a preliminary report suggested it might be effective… CONTINUE READING